 |
|
Acupuncture and Amitriptyline for Pain Due to HIV-Related Peripheral Neuropathy
A Randomized Controlled Trial
Judith C. Shlay, MD;
Kathryn Chaloner, PhD;
Mitchell B. Max, MD;
Bob Flaws, Dipl, Ac;
Patricia Reichelderfer, PhD;
Deborah Wentworth, MPH;
Shauna Hillman, MS;
Barbara Brizz, BSN, MHSEd;
David L. Cohn, MD;
for the Terry Beirn Community Programs for Clinical Research on AIDS
JAMA. 1998;280:1590-1595.
Context.— Peripheral neuropathy is common in persons infected with the human immunodeficiency virus (HIV) but few data on symptomatic treatment are available.
Objective.— To evaluate the efficacy of a standardized acupuncture regimen (SAR) and amitriptyline hydrochloride for the relief of pain due to HIV-related peripheral neuropathy in HIV-infected patients.
Design.— Randomized, placebo-controlled, multicenter clinical trial. Each site enrolled patients into 1 of the following 3 options: (1) a modified double-blind 2 x 2 factorial design of SAR, amitriptyline, or the combination compared with placebo, (2) a modified double-blind design of an SAR vs control points, or (3) a double-blind design of amitriptyline vs placebo.
Setting.— Terry Beirn Community Programs for Clinical Research on AIDS (HIV primary care providers) in 10 US cities.
Patients.— Patients with HIV-associated, symptomatic, lower-extremity peripheral neuropathy. Of 250 patients enrolled, 239 were in the acupuncture comparison (125 in the factorial option and 114 in the SAR option vs control points option), and 136 patients were in the amitriptyline comparison (125 in the factorial option and 11 in amitriptyline option vs placebo option).
Interventions.— Standarized acupuncture regimen vs control points, amitriptyline (75 mg/d) vs placebo, or both for 14 weeks.
Main Outcome Measure.— Changes in mean pain scores at 6 and 14 weeks, using a pain scale ranging from 0.0 (no pain) to 1.75 (extremely intense), recorded daily.
Results.— Patients in all 4 groups showed reduction in mean pain scores at 6 and 14 weeks compared with baseline values. For both the acupuncture and amitriptyline comparisons, changes in pain score were not significantly different between the 2 groups. At 6 weeks, the estimated difference in pain reduction for patients in the SAR group compared with those in the control points group (a negative value indicates a greater reduction for the "active" treatment) was 0.01 (95% confidence interval [CI], -0.11 to 0.12; P =.88) and for patients in the amitriptyline group vs those in the placebo group was -0.07 (95% CI, -0.22 to 0.08; P=.38). At 14 weeks, the difference for those in the SAR group compared with those in the control points group was -0.08 (95% CI, -0.21 to 0.06; P=.26) and for amitriptyline compared with placebo was 0.00 (95% CI, -0.18 to 0.19; P=.99).
Conclusions.— In this study, neither acupuncture nor amitriptyline was more effective than placebo in relieving pain caused by HIV-related peripheral neuropathy.
From the Denver Community Programs for Clinical Research on AIDS, Denver, Colo (Drs Shlay and Cohn); School of Statistics, University of Minnesota, St Paul (Dr Chaloner); National Institute of Dental Research (Dr Max) and National Institute of Allergy and Infectious Diseases (Dr Reichelderfer), National Institutes of Health, Bethesda, Md; Division of Biostatistics, University of Minnesota, Minneapolis (Mss Wentworth and Hillman); and Social and Scientific Systems, Inc, Rockville, Md (Ms Brizz). Mr Flaws is an acupuncturist practicing in Boulder, Colo.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED LETTER
Acupuncture and Amitriptyline for HIV-Related Peripheral Neuropathic Pain
Ted J. Kaptchuk, George A. Ulett, Steven A. King, Judith C. Shlay, David L. Cohn, Kathryn Chaloner, Mitchell B. Max, Patricia Reichelderfer, Bob Flaws, Deborah Wentworth, Shauna Hillman, and Barbara Brizz
JAMA. 1999;281(14):1270-1272.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Amitriptyline in the Prevention of Chemotherapy-induced Neuropathic Symptoms
KAUTIO et al.
Anticancer Res 2009;29:2601-2606.
ABSTRACT
| FULL TEXT
Acupuncture for systemic lupus erythematosus: a pilot RCT feasibility and safety study
Greco et al.
Lupus 2008;17:1108-1116.
ABSTRACT
Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy
Simpson et al.
Neurology 2008;70:2305-2313.
ABSTRACT
| FULL TEXT
Clinical trial outcome in neuropathic pain: Relationship to study characteristics
Katz et al.
Neurology 2008;70:263-272.
ABSTRACT
| FULL TEXT
Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain
Wallace et al.
Brain 2007;130:2688-2702.
ABSTRACT
| FULL TEXT
Complementary Therapies and Integrative Oncology in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition)
Cassileth et al.
Chest 2007;132:340S-354S.
ABSTRACT
| FULL TEXT
Cannabis in painful HIV-associated sensory neuropathy: A randomized placebo-controlled trial
Abrams et al.
Neurology 2007;68:515-521.
ABSTRACT
| FULL TEXT
Small-fiber neuropathy: answering the burning questions.
Fink and Oaklander
Sci Aging Knowl Environ 2006;2006:pe7-pe7.
ABSTRACT
| FULL TEXT
Human Immunodeficiency Virus-Associated Peripheral Neuropathies
Ferrari et al.
Mayo Clin Proc. 2006;81:213-219.
ABSTRACT
| FULL TEXT
A Randomized Clinical Trial of Acupuncture Compared with Sham Acupuncture in Fibromyalgia
Assefi et al.
ANN INTERN MED 2005;143:10-19.
ABSTRACT
| FULL TEXT
Integrative Oncology: Complementary Therapies for Pain, Anxiety, and Mood Disturbance
Deng and Cassileth
CA Cancer J Clin 2005;55:109-116.
ABSTRACT
| FULL TEXT
Case 16-2004 - A 76-Year-Old Woman with Numbness and Pain in the Feet and Legs
Amato and Oaklander
NEJM 2004;350:2181-2189.
FULL TEXT
Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials
Fergusson et al.
BMJ 2004;328:432.
ABSTRACT
| FULL TEXT
Advances in Neuropathic Pain: Diagnosis, Mechanisms, and Treatment Recommendations
Dworkin et al.
Arch Neurol 2003;60:1524-1534.
ABSTRACT
| FULL TEXT
A Behavioral-Medicine Program in HIV: Implications for Quality of Life
Nicholas et al.
J Holist Nurs 2003;21:163-178.
ABSTRACT
Lamotrigine for HIV-associated painful sensory neuropathies: A placebo-controlled trial
Simpson et al.
Neurology 2003;60:1508-1514.
ABSTRACT
| FULL TEXT
Painful Sensory Neuropathy
Mendell and Sahenk
NEJM 2003;348:1243-1255.
FULL TEXT
Use of Psychotropic Medications Among HIV-Infected Patients in the United States
Vitiello et al.
Am. J. Psychiatry 2003;160:547-554.
ABSTRACT
| FULL TEXT
Drug treatment of neuropathic pain
DTB 2000;38:89-93.
ABSTRACT
| FULL TEXT
Remedies for HIV-associated peripheral neuropathy
Berger and Nath
Neurology 2000;54:2037-2038.
FULL TEXT
A placebo-controlled trial of lamotrigine for painful HIV-associated neuropathy
Simpson et al.
Neurology 2000;54:2115-2119.
ABSTRACT
| FULL TEXT
Acupuncture and Amitriptyline for HIV-Related Peripheral Neuropathic Pain
Kaptchuk et al.
JAMA 1999;281:1270-1272.
FULL TEXT
Alternative Medicine Meets Science
Fontanarosa and Lundberg
JAMA 1998;280:1618-1619.
FULL TEXT
|
